BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37440261)

  • 1. Determining a Worldwide Prevalence of Oculocutaneous Albinism: A Systematic Review.
    Kromberg JGR; Flynn KA; Kerr RA
    Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):14. PubMed ID: 37440261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.
    Grønskov K; Ek J; Sand A; Scheller R; Bygum A; Brixen K; Brondum-Nielsen K; Rosenberg T
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1058-64. PubMed ID: 19060277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TYPES OF ALBINISM IN THE BLACK SOUTHERN AFRICA POPULATION.
    Kromberg JG; Bothwell J; Kidson SH; Manga P; Kerr R; Jenkins T
    East Afr Med J; 2012 Jan; 89(1):20-7. PubMed ID: 26845807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of candidate gene mutations associated with Indian familial oculocutaneous and ocular albinism.
    Renugadevi K; Sil AK; Perumalsamy V; Sundaresan P
    Mol Vis; 2010 Aug; 16():1514-24. PubMed ID: 20806075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility gene card for oculocutaneous (OCA) and ocular albinism (OA)-an update.
    Aamir A; Kuht HJ; Grønskov K; Brooks BP; Thomas MG
    Eur J Hum Genet; 2021 Oct; 29(10):1577-1583. PubMed ID: 33504991
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA variations in oculocutaneous albinism: an updated mutation list and current outstanding issues in molecular diagnostics.
    Simeonov DR; Wang X; Wang C; Sergeev Y; Dolinska M; Bower M; Fischer R; Winer D; Dubrovsky G; Balog JZ; Huizing M; Hart R; Zein WM; Gahl WA; Brooks BP; Adams DR
    Hum Mutat; 2013 Jun; 34(6):827-35. PubMed ID: 23504663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B).
    Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE
    Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculocutaneous albinism.
    Grønskov K; Ek J; Brondum-Nielsen K
    Orphanet J Rare Dis; 2007 Nov; 2():43. PubMed ID: 17980020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albinism in Africa as a public health issue.
    Hong ES; Zeeb H; Repacholi MH
    BMC Public Health; 2006 Aug; 6():212. PubMed ID: 16916463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oculocutaneous albinism: epidemiology, genetics, skin manifestation, and psychosocial issues.
    Ma EZ; Zhou AE; Hoegler KM; Khachemoune A
    Arch Dermatol Res; 2023 Mar; 315(2):107-116. PubMed ID: 35217926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case for the inclusion of oculocutaneous albinism as a skin-related Neglected Tropical Disease].
    Aquaron R; Lund P; Baker C
    Med Trop Sante Int; 2023 Dec; 3(4):. PubMed ID: 38390024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Study of the Phenotypic and Mutational Spectrum of Ocular Albinism and Oculocutaneous Albinism.
    Chan HW; Schiff ER; Tailor VK; Malka S; Neveu MM; Theodorou M; Moosajee M
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33808351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oculocutaneous and ocular albinism].
    Kubasch AS; Meurer M
    Hautarzt; 2017 Nov; 68(11):867-875. PubMed ID: 29018889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of nonmelanoma skin cancer in a population of patients with oculocutaneous albinism in Haiti.
    Hassan S; Louis SJ; Fethiere M; Dure D; Rosen J; Morrison BW
    Int J Dermatol; 2022 Jul; 61(7):867-871. PubMed ID: 35393655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-phenotype associations in Danish patients with ocular and oculocutaneous albinism.
    Kessel L; Kjer B; Lei U; Duno M; Grønskov K
    Ophthalmic Genet; 2021 Jun; 42(3):230-238. PubMed ID: 33612058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analyses of oculocutaneous albinism types 1 and 2 with four novel mutations.
    Yang Q; Yi S; Li M; Xie B; Luo J; Wang J; Rong X; Zhang Q; Qin Z; Hang L; Feng S; Fan X
    BMC Med Genet; 2019 Jun; 20(1):106. PubMed ID: 31196117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetics of oculocutaneous albinism].
    Zühlke C; Stell A; Käsmann-Kellner B
    Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phenotype of the visual system in oculocutaneous and ocular albinism].
    Käsmann-Kellner B; Seitz B
    Ophthalmologe; 2007 Aug; 104(8):648-61. PubMed ID: 17684749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.